Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 100, Issue 3, Pages 625-635
Publisher
Wiley
Online
2016-03-01
DOI
10.1189/jlb.5a1215-580r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment
- (2014) Romana Mikyšková et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs
- (2014) Masoud H. Manjili et al. Frontiers in Immunology
- Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
- (2013) Kyle K. Payne et al. BREAST CANCER RESEARCH AND TREATMENT
- Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
- (2013) Lisa M. Kopp et al. MOLECULAR IMMUNOLOGY
- Potential role of 5-Aza-2′-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer
- (2013) Viswanath Gunda et al. SURGERY
- Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
- (2012) Amir A. Toor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Innate IFN- Is Essential for Programmed Death Ligand-1-Mediated T Cell Stimulation following Listeria monocytogenes Infection
- (2012) J. H. Rowe et al. JOURNAL OF IMMUNOLOGY
- Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation
- (2012) Jennifer L. Berrie et al. TRANSPLANTATION
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment
- (2011) Jung-Mi Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse
- (2011) M. Kmieciak et al. JOURNAL OF IMMUNOLOGY
- The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
- (2011) S. Amarnath et al. Science Translational Medicine
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design
- (2008) Maciej Kmieciak et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors
- (2008) A. Worschech et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now